首页> 外国专利> Crystalline form c dipropilcarbamoilmetilo succinate Ester acid 3 - (3 - 2 - (e) - 3.5 - diamino - 6 - Chloro - carbonilimino pyrazine - 2 - - - - 1,3,8 triaza spiro 4.5 Dean - 8 - carbonyl} - bencenosulfonilamino) - propionic acid; Pharmaceutical Composition and Inhalation Device he understands; and its use for the Treatment of respiratory diseases such as COPD and Asthma.

Crystalline form c dipropilcarbamoilmetilo succinate Ester acid 3 - (3 - 2 - (e) - 3.5 - diamino - 6 - Chloro - carbonilimino pyrazine - 2 - - - - 1,3,8 triaza spiro 4.5 Dean - 8 - carbonyl} - bencenosulfonilamino) - propionic acid; Pharmaceutical Composition and Inhalation Device he understands; and its use for the Treatment of respiratory diseases such as COPD and Asthma.

机译:结晶形式c丙酸氨基甲酸丁二酯琥珀酸酯3-(3-[2-[(e)-3.5-二氨基-6-氯代-碳-氨基)吡嗪-2----1,3,8 triaza spiro [4.5] Dean-8 -羰基}-苯磺酰氨基)-丙酸;他了解药物成分和吸入装置;及其用于治疗呼吸道疾病如COPD和哮喘的用途。

摘要

This invention relates to a new crystalline form of the succinate salt of the epithelial sodium channel (ENaC) blocker 3-(3-{2-[(E)-3,5-Diamino-6-chloro-pyrazine-2-carbonylimino]-1,3,8-triaza-spiro[4.5]decane-8-carbonyl}-benzenesulfonylamino)-propionic acid dipropylcarbamoylmethyl ester, pharmaceutical compositions comprising said crystalline form, uses of said crystalline form and pharmaceutical compositions, and methods for preparing said crystalline form.
机译:本发明涉及上皮钠通道(ENaC)阻滞剂3-(3- {2-[((E)-3,5-Diamino-6-chloro-吡嗪-2-羰基亚氨基)]的琥珀酸盐的新结晶形式。 -1,3,8-三氮杂螺[4.5]癸烷-8-羰基}-苯磺酰氨基)-丙酸二丙基氨基甲酰基甲基酯,包含所述晶型的药物组合物,所述晶型和药物组合物的用途以及制备所述晶型的方法形成。

著录项

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号